Two Sigma Investments’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-312,426
| Closed | -$4.91M | – | 3437 |
|
|
2024
Q1 | $4.91M | Sell |
312,426
-95,506
| -23% | -$1.47M | 0.01% | 982 |
|
|
2023
Q4 | $6.58M | Buy |
407,932
+378,226
| +1,273% | +$4.82M | 0.02% | 852 |
|
|
2023
Q3 | $378K | Sell |
29,706
-70,000
| -70% | -$966K | ﹤0.01% | 2398 |
|
|
2023
Q2 | $1.4M | Sell |
99,706
-79,000
| -44% | -$1.13M | ﹤0.01% | 1738 |
|
|
2023
Q1 | $2.76M | Sell |
178,706
-179,847
| -50% | -$3M | 0.01% | 1190 |
|
|
2022
Q4 | $5.88M | Buy |
358,553
+49,853
| +16% | +$811K | 0.02% | 788 |
|
|
2022
Q3 | $5.71M | Buy |
308,700
+151,631
| +97% | +$2.38M | 0.02% | 706 |
|
|
2022
Q2 | $2.06M | Buy |
+157,069
| New | +$1.73M | 0.01% | 1187 |
|
|
2022
Q1 | – | Sell |
-152,649
| Closed | -$1.49M | – | 4628 |
|
|
2021
Q4 | $1.49M | Buy |
+152,649
| New | +$2.87M | ﹤0.01% | 2199 |
|
|
2020
Q3 | – | Sell |
-97,854
| Closed | -$5.84M | – | 3669 |
|
|
2020
Q2 | $5.84M | Sell |
97,854
-20,801
| -18% | -$1.11M | 0.03% | 590 |
|
|
2020
Q1 | $4.88M | Buy |
118,655
+68,760
| +138% | +$3.82M | 0.04% | 521 |
|
|
2019
Q4 | $3.1M | Buy |
49,895
+8,874
| +22% | +$422K | 0.01% | 1261 |
|
|
2019
Q3 | $1.39M | Buy |
+41,021
| New | +$1.21M | ﹤0.01% | 1714 |
|
|
2018
Q3 | – | Sell |
-11,900
| Closed | -$468K | – | 3697 |
|
|
2018
Q2 | $468K | Buy |
+11,900
| New | +$350K | ﹤0.01% | 2695 |
|
Other funds holding DCPH
Two Sigma Investments's DCPH Position: Q2 2024 in Review
Two Sigma Investments sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 312,426 shares — an estimated $4.91M sold.
Two Sigma Investments first reported a position in DCPH in Q2 2018 and held it in 14 quarters. The position peaked at $6.58M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Two Sigma Investments reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Two Sigma Investments sold 312,426 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $4.91M.
- Two Sigma Investments first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 14 quarters.
- Two Sigma Investments's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $6.58M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.